HN2003000048A - COMPRESSED NELFINAVIR OF INCREASED DOSE AND METHOD TO MANUFACTURE IT - Google Patents
COMPRESSED NELFINAVIR OF INCREASED DOSE AND METHOD TO MANUFACTURE ITInfo
- Publication number
- HN2003000048A HN2003000048A HN2003000048A HN2003000048A HN2003000048A HN 2003000048 A HN2003000048 A HN 2003000048A HN 2003000048 A HN2003000048 A HN 2003000048A HN 2003000048 A HN2003000048 A HN 2003000048A HN 2003000048 A HN2003000048 A HN 2003000048A
- Authority
- HN
- Honduras
- Prior art keywords
- nelfinavir
- compressed
- manufacture
- increased dose
- present
- Prior art date
Links
- QAGYKUNXZHXKMR-UHFFFAOYSA-N CPD000469186 Natural products CC1=C(O)C=CC=C1C(=O)NC(C(O)CN1C(CC2CCCCC2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-UHFFFAOYSA-N 0.000 title abstract 3
- QAGYKUNXZHXKMR-HKWSIXNMSA-N nelfinavir Chemical compound CC1=C(O)C=CC=C1C(=O)N[C@H]([C@H](O)CN1[C@@H](C[C@@H]2CCCC[C@@H]2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-HKWSIXNMSA-N 0.000 title abstract 3
- 229960000884 nelfinavir Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glanulating (AREA)
Abstract
LA PRESENTE INVENCION SE DIRIGE A UNA FORMA DE ELEVADA DOSIFICACION DE COMPRIMIDOS DE NELFINAVIR Y A UN METODO PARA FABRICAR DICHOS COMPRIMIDOS . MAS PARTICULARMENTE LA PRESENTE INVENCION SE DIRIGE A COMPRIMIDOS DE NELFINAVIR QUE TIENEN UNA DOSIS SIGNIFICATIVAMENTE MAYOR QUE LOS COMPIMIDOS DISPONIBLES ACTUALMENTE, PARA REDUCIR LA CARGA DE PILDORA DEL PACIENTE.THE PRESENT INVENTION IS DIRECTED TO A FORM OF HIGH DOSAGE OF NELFINAVIR TABLETS AND A METHOD FOR MANUFACTURING SUCH COMPRESSED TABLES. MORE PARTICULARLY THE PRESENT INVENTION IS ADDRESSED TO NELFINAVIR TABLETS THAT HAVE A DIFFERENTLY GREATER DOSE THAN THE CURRENTLY AVAILABLE COMPARTMENTS, TO REDUCE THE PATIENT'S PILLING LOAD.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35142002P | 2002-01-28 | 2002-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HN2003000048A true HN2003000048A (en) | 2003-10-28 |
Family
ID=27663002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HN2003000048A HN2003000048A (en) | 2002-01-28 | 2003-01-27 | COMPRESSED NELFINAVIR OF INCREASED DOSE AND METHOD TO MANUFACTURE IT |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1469836A1 (en) |
| JP (1) | JP2005521661A (en) |
| KR (1) | KR20040079952A (en) |
| CN (1) | CN1713895A (en) |
| AR (1) | AR038236A1 (en) |
| BR (1) | BR0307190A (en) |
| CA (1) | CA2398226A1 (en) |
| GT (1) | GT200300016A (en) |
| HN (1) | HN2003000048A (en) |
| HU (1) | HUP0500512A2 (en) |
| IL (1) | IL162724A0 (en) |
| MX (1) | MXPA04007237A (en) |
| NI (1) | NI200300001A (en) |
| NO (1) | NO20043238L (en) |
| NZ (1) | NZ533283A (en) |
| PA (1) | PA8564301A1 (en) |
| PE (1) | PE20030730A1 (en) |
| PL (1) | PL373882A1 (en) |
| RU (1) | RU2004123206A (en) |
| SV (1) | SV2004001467A (en) |
| TW (1) | TW200302111A (en) |
| WO (1) | WO2003063837A1 (en) |
| ZA (1) | ZA200404367B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008053276A1 (en) * | 2006-10-30 | 2008-05-08 | Collette Nv | Transition piece for the transfer of powder or granular material from a discharge opening to a conveying line and method of transferring powder or granular material |
| AU2007358602A1 (en) * | 2007-09-03 | 2009-03-12 | Lucent Technologies Inc. | Method and system for checking automatically connectivity status of an IP link on IP network |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6499984B1 (en) * | 2000-05-22 | 2002-12-31 | Warner-Lambert Company | Continuous production of pharmaceutical granulation |
| MXPA03009971A (en) * | 2001-05-03 | 2004-02-12 | Hoffmann La Roche | Pharmaceutical dosage form of amorphous nelfinavir mesylate. |
-
2002
- 2002-08-15 CA CA002398226A patent/CA2398226A1/en not_active Abandoned
-
2003
- 2003-01-07 NI NI200300001A patent/NI200300001A/en unknown
- 2003-01-16 NZ NZ533283A patent/NZ533283A/en unknown
- 2003-01-16 WO PCT/IB2003/000117 patent/WO2003063837A1/en not_active Ceased
- 2003-01-16 EP EP03700070A patent/EP1469836A1/en not_active Withdrawn
- 2003-01-16 BR BR0307190-1A patent/BR0307190A/en not_active IP Right Cessation
- 2003-01-16 MX MXPA04007237A patent/MXPA04007237A/en unknown
- 2003-01-16 HU HU0500512A patent/HUP0500512A2/en unknown
- 2003-01-16 RU RU2004123206/15A patent/RU2004123206A/en not_active Application Discontinuation
- 2003-01-16 KR KR10-2004-7011562A patent/KR20040079952A/en not_active Ceased
- 2003-01-16 JP JP2003563531A patent/JP2005521661A/en active Pending
- 2003-01-16 CN CNA038028360A patent/CN1713895A/en active Pending
- 2003-01-16 PL PL03373882A patent/PL373882A1/en not_active Application Discontinuation
- 2003-01-16 IL IL16272403A patent/IL162724A0/en unknown
- 2003-01-24 PE PE2003000074A patent/PE20030730A1/en not_active Application Discontinuation
- 2003-01-27 AR ARP030100228A patent/AR038236A1/en unknown
- 2003-01-27 SV SV2003001467A patent/SV2004001467A/en not_active Application Discontinuation
- 2003-01-27 TW TW092101739A patent/TW200302111A/en unknown
- 2003-01-27 HN HN2003000048A patent/HN2003000048A/en unknown
- 2003-01-28 GT GT200300016A patent/GT200300016A/en unknown
- 2003-01-28 PA PA20038564301A patent/PA8564301A1/en unknown
-
2004
- 2004-06-03 ZA ZA200404367A patent/ZA200404367B/en unknown
- 2004-08-02 NO NO20043238A patent/NO20043238L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20043238L (en) | 2004-08-02 |
| CA2398226A1 (en) | 2003-07-28 |
| RU2004123206A (en) | 2005-04-20 |
| PA8564301A1 (en) | 2003-09-05 |
| GT200300016A (en) | 2003-09-11 |
| HUP0500512A2 (en) | 2005-09-28 |
| NI200300001A (en) | 2004-12-21 |
| KR20040079952A (en) | 2004-09-16 |
| WO2003063837A1 (en) | 2003-08-07 |
| CN1713895A (en) | 2005-12-28 |
| IL162724A0 (en) | 2005-11-20 |
| AR038236A1 (en) | 2005-01-05 |
| BR0307190A (en) | 2004-11-03 |
| JP2005521661A (en) | 2005-07-21 |
| PL373882A1 (en) | 2005-09-19 |
| MXPA04007237A (en) | 2004-10-29 |
| NZ533283A (en) | 2006-12-22 |
| ZA200404367B (en) | 2006-05-31 |
| TW200302111A (en) | 2003-08-01 |
| EP1469836A1 (en) | 2004-10-27 |
| SV2004001467A (en) | 2004-05-07 |
| PE20030730A1 (en) | 2003-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2002000389A (en) | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM DRUG | |
| PA8616201A1 (en) | PHARMACEUTICAL COMPOSITIONS OF SUSTAINED LIBERATION | |
| UY30537A1 (en) | FLIBANSERIN FORMULATIONS AND METHOD TO MANUFACTURE THEM | |
| ECSP055569A (en) | DOSAGE FORM OF PRAMIPEXOL IN A SINGLE DAILY DOSE | |
| EE200400020A (en) | Substituted oxazolidinones for combination therapy | |
| AR038527A1 (en) | DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS ACTIVE INGREDIENT | |
| ECSP14013160A (en) | PROCEDURE FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION IN THE FORM OF PROLONGED RELEASE TABLETS CONTAINING PYRFENIDONE AND ITS APPLICATION IN THE REGRESSION OF CHRONIC RENAL FAILURE, MAMMARY CAPSULAR CONTRACTURE AND HEPATIC FIBROSIS HU | |
| AR028959A1 (en) | USE OF RAPAMYCIN FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT CARDIOVASCULAR DISEASES | |
| AR034900A1 (en) | USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT | |
| AR109263A2 (en) | COMPOSITION INCLUDING MOXIDECTINE | |
| GT200500003A (en) | PHARMACEUTICAL COMPOSITION SUITABLE FOR DIRECT COMPRESSION FOR ORAL ADMINISTRATION OF CCI-779 | |
| CL2004000452A1 (en) | USE OF AN ANTIEPILEPTIC COMPOUND CONTAINING PAIN RELIEF PROPERTIES AND TWO OR MORE COMPOUNDS OF THE GROUP FORMED BY ANDAGONIST OF THE NMDA SELECTIVES OF SUBTIPO, ANALGESICOS, NSAID, AND COMBINATIONS OF THEM, FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
| CR8603A (en) | HYDROCLORIDE OF [4- (5-AMINOMETIL-2-FLUORO-PHENYL) -PIPERIDIN-1-IL] - (4-BROMO-3-METHYL-5-PROPOXI-THIOFEN-2-IL) -METANONE AS AN INHIBITOR OF THE MASTOCYT TRIPTASE | |
| DE60102590T2 (en) | PHARMACEUTICAL FORMS FOR THE TREATMENT OF ORAL MYCOSES | |
| PE20031047A1 (en) | TREATMENT OF POST-MENOPAUSAL PATIENTS IN PATIENTS WITH BREAST CANCER | |
| AR021086A1 (en) | OMEGA-AMIDAS OF N-ARILSULFONIL-AMINO ACIDS, A PROCEDURE FOR THE PREPARATION, MEDICATION, USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT. | |
| AR026010A1 (en) | ORAL DOSING UNIT ORALALLY DISARNING CONTAINING THE MIRTAZAPINE ANTIDEPRESSIVE AS ACTIVE INGREDIENT | |
| HN2003000048A (en) | COMPRESSED NELFINAVIR OF INCREASED DOSE AND METHOD TO MANUFACTURE IT | |
| PA8549401A1 (en) | COMPLEX THAT INCLUDES INHIBITING FACTOR OF OSTEOCLASTOGENESIS AND POLISACARIDO | |
| AR036009A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VISCERAL PAIN AND GASTROINTESTINAL DISORDERS THAT INCLUDE A BICYCLIC AMINO ACID COMPOUND AND USE OF THIS LAST TO MANUFACTURE SUCH PHARMACEUTICAL COMPOSITION | |
| CL2004000767A1 (en) | ORAL DOSING UNIT INCLUDING AN ANTAGONIST AGENT FOR PUMPS OF PROTONS AND EXCIPIENTS OF BASIC CHARACTER; PROCEDURE FOR PREPARATION, USEFUL TO TREAT DISEASES CAUSED BY AN INCREASED SECRETION OF GASTRIC ACIDS. | |
| PL378106A1 (en) | Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by said method | |
| CL2022000095A1 (en) | Pharmaceutical compositions resistant to the discharge of doses that comprise venirunad | |
| PA8651401A1 (en) | SOLID ORAL DOSAGE FORMS CONTAINING A LOW ESTRADIOL DOSE | |
| PA8558501A1 (en) | 1,3-DIARILPROP-2-EN1-ONAS, COMPOSITIONS THAT CONTAIN THEM AND ITS USE |